Phase I/Ii study of combination high-dose therapy with busulfan, thiotepa, and total body irradiation (TBI) for the treatment of aggressive multiple myeloma

Jose F. Leis, Keith S. Hansen, Mark W. Brunvand, William H. Fleming

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I/Ii study of combination high-dose therapy with busulfan, thiotepa, and total body irradiation (TBI) for the treatment of aggressive multiple myeloma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences